Pharmaceuticals News

TME Pharma publie les résultats de l'essai GLORIA sur la trithérapie NOX-A12 dans *Nature Communications* ; des discussions en vue d'un partenariat sont en

TME Pharma publishes NOX-A12 triple therapy GLORIA trial data in Nature Communications; partnership talks ongoing.

EUROBIO SCIENTIFIC SIGNS DEFINITIVE AGREEMENT TO ACQUIRE CAREDX’s TRANSPLANT LAB PRODUCT DIVISION Acquisition of CareDx’s ‘lab products’ portfolio creates new opportunities for growth and innovation...

EUROBIO SCIENTIFIC SIGNE UN ACCORD DÉFINITIF EN VUE DE L'ACQUISITION DE LA DIVISION « LAB PRODUCTS1 » DE CAREDX DÉDIÉE À LA TRANSPLANTATION L'acquisition du portefeuille « Lab Products » de CareDx...

Pharming Group N.V. 2026 Annual General Meeting to be be held on Thursday May 28, 2026, at 14:00 CET. Meeting documents available on website Pharming.com.

Greywolf Therapeutics appoints renowned biotech entrepreneur Dr Edwin Moses as Chair, bringing 30+ years of life sciences leadership

KØBENHAVN, Danmark, 16. april 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag, at det schweiziske lægemiddelagentur, Swiss Agency for Therapeutic Products (Swissmedic), har godkendt...

COPENHAGEN, Denmark, April 16, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that the Swiss Agency for Therapeutic Products, Swissmedic, has approved VIMKUNYA® (recombinant, adsorbed) for...

BASEL, Switzerland, April 16, 2026 (GLOBE NEWSWIRE) -- BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated...

SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...